Burrill & Company is a San Francisco-based merchant bank with a venture capital investment arm that invests across the spectrum of life sciences. It focuses its efforts on building value in portfolio companies involved in biotechnology, pharmaceuticals, diagnostics, devices, human healthcare and related medical technologies. Burrill preserves an investment focus on the US and Europe, but has global interests and also actively pursues investments in emerging markets such as Brazil and Asia.In 2014, the firm was sued and ousted as GP of Burrill Life Sciences Capital Fund III and IV as the venture capital fund paid USD 19 million to various designees and affiliates of the general partner in excess of management fees that had been earned.
Venture Capital
8 funds found in our dataset.
Built for investment teams that need to move faster.
Intelligently process data room financials, generate auditable analyses, and export IC-ready deliverables.